Multiple Risk Factors in Cardiovascular Disease: Strategies of Prevention of Coronary Heart Disease, Cardiac Failure, and Stroke: Medical Science Symposia Series, cartea 12
Editat de Antonio M. Gotto Jr., Claude Lenfant, Rodolfo Paoletti, Alberico L. Catapano, Ann S. Jacksonen Limba Engleză Paperback – 5 noi 2012
Din seria Medical Science Symposia Series
- 5% Preț: 368.37 lei
- 5% Preț: 391.79 lei
- 5% Preț: 657.90 lei
- 5% Preț: 373.12 lei
- 5% Preț: 658.63 lei
- 5% Preț: 1102.67 lei
- 5% Preț: 646.58 lei
- 5% Preț: 359.98 lei
- 5% Preț: 777.55 lei
- 5% Preț: 707.69 lei
- 18% Preț: 948.92 lei
- 5% Preț: 1111.26 lei
- 15% Preț: 641.38 lei
- 5% Preț: 382.26 lei
- 5% Preț: 375.13 lei
- 5% Preț: 711.15 lei
- 5% Preț: 1426.33 lei
- 5% Preț: 1408.60 lei
- Preț: 386.99 lei
- 5% Preț: 377.52 lei
- 5% Preț: 1101.21 lei
Preț: 374.05 lei
Preț vechi: 393.74 lei
-5% Nou
Puncte Express: 561
Preț estimativ în valută:
71.58€ • 74.28$ • 59.83£
71.58€ • 74.28$ • 59.83£
Carte tipărită la comandă
Livrare economică 17-31 martie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9789401061087
ISBN-10: 9401061084
Pagini: 388
Ilustrații: XVII, 371 p.
Dimensiuni: 160 x 240 x 25 mm
Greutate: 0.55 kg
Ediția:Softcover reprint of the original 1st ed. 1998
Editura: SPRINGER NETHERLANDS
Colecția Springer
Seria Medical Science Symposia Series
Locul publicării:Dordrecht, Netherlands
ISBN-10: 9401061084
Pagini: 388
Ilustrații: XVII, 371 p.
Dimensiuni: 160 x 240 x 25 mm
Greutate: 0.55 kg
Ediția:Softcover reprint of the original 1st ed. 1998
Editura: SPRINGER NETHERLANDS
Colecția Springer
Seria Medical Science Symposia Series
Locul publicării:Dordrecht, Netherlands
Public țintă
ResearchCuprins
I. Plasma Lipids and Lipoproteins.- New Insights into the Role of HDL in the Development of Cardiovascular Disease.- Mechanisms of the Hypolipidemic Action of Fibrates.- Lipid Lowering Drugs and the Arterial Wall.- Perspectives on Lipid-Lowering Therapy: Past and Present.- II. Coagulation, Fibrinolysis, and Platelet Inhibition.- Role of the Fibrinolytic and the Coagulation System in the Formation and Disorders of Blood Vessels.- Evolving Understanding of Coronary Thrombosis and New Insights into Therapeutic Strategies.- Platelet Activation and Carotid Arterial Atherothrombosis.- III. Emerging Risk Factors for Cardiovascular Disease.- Tissue Factor and the Regulation of Arterial Thrombosis.- Fibrinogen: Risk Factor or Risk Marker?.- PAI-1 and the Risk of Cardiovascular Disease.- Plasma Homocyst(e)ine [H(e)] and Arterial Occlusive Diseases: Gene-Nutrient Interactions.- IV. Risk Factors and Intervention: National Initiatives.- The Role of Social and Psychoemotional Factors in the Development of Cardiovascular Disease: The Experience in Eastern European Countries.- European Action on Secondary Prevention.- Cardiovascular Risk Factors in Normotensive and Hypertensive Egyptians: Preliminary Results, Egyptian National Hypertension Project (NHP).- V. LDL Oxidation, Antioxidants, and Atherosclerosis.- Lipid Deposition and Oxidation in the Evolution of the Atherosclerotic Lesion: Lessons Learned from Hypercholesterolemic Animal Models.- Oxidative Modification of LDL and Atherogenesis.- Dietary Antioxidants and Cardiovascular Disease.- Is “Antioxidant Status” a Risk Factor?.- VI. Diabetes.- Diabetes and Atherosclerosis: Risk Factors and Clinical Trials.- Insulin Resistance: What, Why, and How.- Diabetes.- Dyslipidemia, Diabetes, and Cell Adhesion Molecules.- Novel TherapeuticApproaches to Insulin Resistance/Diabetic Dyslipidemia.- VII. Genetic Determinants of Cardiovascular Disease.- Hypertension and Thrombosis, Genetic Determinants of Cardiovascular Disease.- Lipoproteins and Cardiovascular Risk. From Genetics to Prevention of Coronary Heart Disease.- Obesity and Diabetes.- Clustering of Cardiovascular Risk Factors.- VIII. Inflammation and Cardiovascular Disease.- Neutrophil-Endothelial Cells Cooperation in the Handling of Leukotrienes: Role in Coronary Inflammation.- Integrin Expression and Macrophage Resistance to Apoptosis in Atherosclerosis.- IX. From Cholesterol to Cardiovascular Events, Where is the Bridge?.- Effect of Statins Beyond Lowering Cholesterol: Where Do We Stand?.- Lessons from Clinical Trials: LCAS and Other Studies.- Improving the Cost Effectiveness of Lipid Lowering Therapy in Coronary Heart Disease Prevention.- X. Lifestyle and Cardiovascular Disease.- Diet and Cardiovascular Disease.- Alcohol and Coronary Heart Disease: A Comparison of Ecologic and Non-Ecologic Studies.- Preventing Cardiovascular Disease: Effective Smoking Cessation Strategies for the Busy Clinician.- XI. Multiple Risk Factors and Cardiovascular Disease.- Risk Factors for Cardiovascular Disease and the Endothelium.- Epidemiology of Risk Factor Clustering in Elevated Blood Pressure.- Hypertension and Coronary Heart Disease Risk Factor Management.- Global Risk Management: New Strategies for Implementation.- XII. Cardiac Failure.- Sudden Cardiac Death in Heart Failure.